9:45 am – 10:45 am Friday, September 16

Using Their Own Words: AYA Cancer Patients as Influencers in COG Clinical Trials (C216)

Adolescent and young adult (AYA) cancer patients continue to be a conundrum for providers, researchers, and health care systems. Previous challenges for AYA oncology care have been identified as delayed diagnosis, lack of insurance, limited clinical trial availability and enrollment, tumor biology, unique toxicity profiles, distinct psychosocial issues, and more. While there has been advancement in the treatment of AYAs with cancer, there is a paucity of information about how that treatment impacts the AYA cancer patient’s life, both during treatment and beyond. Read more...
4:15 pm – 5:15 pm Friday, September 16

Hot Topics in Pediatric Oncology: Updates from the Children’s Oncology Group (C222)

Despite the pandemic, the Children’s Oncology Group (COG) has produced 237 publications since the beginning of 2020. The magnitude of this productivity makes it difficult for health care professionals to remain up to date with new knowledge. The purpose of this presentation is to highlight results from four recent, COG publications and assist nurses in translating evidence into their practice.  Read more...
3:45 pm – 4:45 pm Thursday, September 15

Targeting Patient and Family Education for ALK/MEK Inhibitor Therapy: What We Learned from the COG Nursing Evidenced Based Project (C204)

coglogoChildren with cancer have historically received multiple modalities of therapy to treat their disease processes including surgery, chemotherapy, radiation and stem cell transplant. These modalities incur the potential for significant acute toxicity and late effects from therapy. In the last decade, the addition of a new modality known as biotherapy has become an integral player in the treatment of pediatric cancers. Biotherapy includes targeted therapies used to attack and destroy cancer cells while minimizing effects on healthy cells and tissue. Read more...
2:30 – 3:30 pm Thursday, September 15

Opening Keynote: Embracing "AND" to Build Resilience: 3 Powerful AND Practical Strategies For Life (101)

Kim Regis is a retired Super Hero. A stroke stopped her life and taught her how to live a full authentic and integrated life. She went from living with a filled and fragmented schedule to strategizing how to put her experience in nursing, operations, and executive leadership to work for the greater good.

Read more...
Speaker:
Kim Regis, DNP RN NEA PNP BCC
CNE Hours
1
3:30 pm – 4:45 pm Saturday, September 17

Closing Keynote: Being The Nurse You Want To Be (105)

The pandemic has created unprecedented challenges for nurses that have eroded their well-being and integrity.  The consequences include a disorienting reality that has challenged many nurses' identity and purpose.  Who are we now? What does it mean to be a nurse in this new reality?  This experiential session will explore the ways nursing identity has evolved during the pandemic, explore the gap between where we are and our desired future, and propose strategies for transforming it to reflect the nurse you want to be. Read more...
Speaker:
Cynda Rushton, PhD RN
CNE Hours
1
8:30 am – 9:30 am Saturday, September 17

General Session: APHON Advocacy: Ask, Tell, Ask (104)

This session will outline the basics of advocacy and APHON’s Advocacy Agenda. Opportunities for engagement in advocacy will be described along with their associated time commitments. A demonstration of making a legislative “ask” will be performed to provide attendees with the tools and confidence they need to advocate for APHON’s priorities locally and nationally. Read more...
8:30 am – 9:30 am Friday, September 16

General Session: State of Nursing: Pediatric Hematopoietic Stem Cell Transplantation: A Glimpse of the Past, Current State, a Glance of the Future (102)

Over the last 60 years, significant advances in in hematopoietic stem cell transplantation (HSCT) has provided improvements in effective treatment or cure and overall survival for many patients. There has been considerable HSCT progress and success in a variety of pediatric malignant and non-malignant diseases. This state of the science presentation will be providing the evolution and current and future highlights of Pediatric HSCT as it relates to disease conditions, stem cell sources, conditioning regimens, cellular immunotherapy, toxicity related treatments and supportive care. Read more...
3:00 pm – 4:00 pm Friday, September 16

General Session: Sickle Cell Disease: Pathophysiology, Pain, and Prevention of Problems (103)

Sickle Cell Disease (SCD) is the most common inherited hemoglobinopathy in the United States; the etiology is a DNA mutation that results in the different amino acids at position 6 of the beta-globin chain, where valine is produced instead of glutamine. The sickling of the red blood cell sets off a cascade of pathology. Vaso occlusion causing ischemia to almost every body system accounts for the majority of morbidity and is the etiology of acute pain episodes. Acute pain episodes account for the majority of health care utilization by this population.

Read more...
2:15 pm – 3:15 pm Saturday, September 17

What the HEC is MEC? Understanding Antiemetic Therapy for Moderately and Highly Emetogenic Chemotherapy (230)

Optimal chemotherapy induced nausea and vomiting (CINV) control has been shown to improve patient’s quality of life and decrease distress. Without good control, both physical and psychological complications can occur, including anorexia, malnutrition, and nutritional deficiency. But what is optimal CINV control? Nausea without vomiting? No nausea? No vomiting? Only vomiting a few times? This definition can mean something different to every patient, provider, and nurse. Read more...
11:00 am – 12:00 pm Saturday, September 17

The Future of Nursing 2020-2030: What We All Need to Know (224)

In 2021, the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM), released the report Future of Nursing (FON) 2020-2030: Charting a Path to Achieve Health Equity. This most recent report is the third report on the future of nursing, initially created with the sponsorship of the Robert Wood Johnson Foundation (RWJF) published in 2011 (National Academy of Sciences). Nurses at all levels need to be familiar with the needs of the profession and how they can get involved and make a difference for themselves and their patients. Read more...
Subscribe to this RSS feed